A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2005
The purpose of this study is to evaluate the safety and effectiveness of once- weekly dosing of PROCRIT® (a glycoprotein that stimulates red blood cell production) versus placebo in the treatment of anemia in children with cancer undergoing chemotherapy, and to assess its effect on the quality of life.
Epistemonikos ID: a90a984951ed7c4f8f63bca153361646042a2de5
First added on: Jan 21, 2022